Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33
- PMID: 17263731
- DOI: 10.1111/j.1742-4658.2007.05670.x
Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33
Abstract
The human UDP-glucuronosyltransferase (UGT) isoforms UGT2B4 and UGT2B7 play a major role in the detoxification of bile acids, steroids and phenols. These two isoforms present distinct but overlapping substrate specificity, sharing common substrates such as the bile acid hyodeoxycholic acid (HDCA) and catechol-estrogens. Here, we show that in UGT2B4, substitution of phenylalanine 33 by leucine suppressed the activity towards HDCA, and impaired the glucuronidation of several substrates, including 4-hydroxyestrone and 17-epiestriol. On the other hand, the substrate specificity of the mutant UGT2B4F33Y, in which phenylalanine was replaced by tyrosine, as found at position 33 of UGT2B7, was similar to wild-type UGT2B4. In the case of UGT2B7, replacement of tyrosine 33 by leucine strongly reduced the activity towards all the tested substrates, with the exception of 17-epiestriol. In contrast, mutation of tyrosine 33 by phenylalanine exhibited similar or even somewhat higher activities than wild-type UGT2B7. Hence, the results strongly indicated that the presence of an aromatic residue at position 33 is important for the activity and substrate specificity of both UGT2B4 and UGT2B7.
Similar articles
-
Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.J Mol Biol. 1999 May 28;289(1):29-39. doi: 10.1006/jmbi.1999.2735. J Mol Biol. 1999. PMID: 10339403
-
Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene.Pharmacogenetics. 1999 Apr;9(2):207-16. Pharmacogenetics. 1999. PMID: 10376768
-
Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.Biochem Pharmacol. 2007 May 1;73(9):1463-73. doi: 10.1016/j.bcp.2006.12.021. Epub 2006 Dec 22. Biochem Pharmacol. 2007. PMID: 17223084
-
Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.Methods Enzymol. 2005;400:104-16. doi: 10.1016/S0076-6879(05)00007-8. Methods Enzymol. 2005. PMID: 16399346 Review.
-
Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors.Biochem Pharmacol. 2012 Oct 15;84(8):1000-6. doi: 10.1016/j.bcp.2012.07.009. Epub 2012 Jul 20. Biochem Pharmacol. 2012. PMID: 22820246 Review.
Cited by
-
Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).J Transl Med. 2021 Apr 15;19(1):151. doi: 10.1186/s12967-021-02816-3. J Transl Med. 2021. PMID: 33858454 Free PMC article.
-
Demethylzeylasteral exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A6 and 2B7.Molecules. 2012 Aug 8;17(8):9469-75. doi: 10.3390/molecules17089469. Molecules. 2012. PMID: 22874791 Free PMC article.
-
The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.AAPS J. 2016 Jul;18(4):830-43. doi: 10.1208/s12248-016-9928-8. Epub 2016 May 16. AAPS J. 2016. PMID: 27184579
-
Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.Drug Metab Dispos. 2015 Jul;43(7):1061-70. doi: 10.1124/dmd.114.061440. Epub 2015 May 6. Drug Metab Dispos. 2015. PMID: 25948711 Free PMC article.
-
Comprehensive variant screening of the UGT gene family.Yonsei Med J. 2014 Jan;55(1):232-9. doi: 10.3349/ymj.2014.55.1.232. Yonsei Med J. 2014. PMID: 24339312 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources